Oral Bisphosphonate Therapy for Osteogenesis Imperfecta: A Systematic Review and Meta‐Analysis of Six Randomized Placebo‐Controlled Trials
Objective To assess the effectiveness and safety of oral bisphosphonates in increasing bone mineral density (BMD), reducing fractures, and improving clinical function in patients with osteogenesis imperfecta (OI). Methods Studies were eligible for inclusion if they were randomized controlled trials...
Main Authors: | Zhi‐min Ying, Bin Hu, Shi‐gui Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Orthopaedic Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1111/os.12611 |
Similar Items
-
BISPHOSPHONATE THERAPY IN PEDIATRIC PATIENTS WITH OSTEOGENESIS IMPERFECTA
by: Alina Murgu, et al.
Published: (2015-06-01) -
Osteogenesis Imperfecta Presented with Vertebral Fractures After Pregnancy and Treatment with Cyclical Etidronate: A Case Report
by: Cengiz Bahadır, et al.
Published: (2005-06-01) -
The effect of bisphosphonate medication on orthodontics and orthognathic surgery in patients with osteogenesis imperfecta
by: Friedrich, Reinhard E., et al.
Published: (2019-03-01) -
Osteogenesis imperfecta
by: Justin Easow Sam, et al.
Published: (2017-01-01) -
Systematic Review on the Incidence of Bisphosphonate Related Osteonecrosis of the Jaw in Children Diagnosed with Osteogenesis Imperfecta
by: Anusha Adeline Hennedige, et al.
Published: (2014-01-01)